In an article detailing the emerging applications of digital health research, Research!America describes the recent developments of emocha. Originally developed by researchers at the Johns Hopkins University School of Medicine to help treat patients with HIV in rural Uganda, emocha is now a mobile app used to improve medication adherence among disease states including tuberculosis, opioid use disorder, HIV, hepatitis C, and other chronic and infectious diseases. With grants from the National Institute of Health and National Institute of Drug Abuse, emocha is well-poised to become a scalable platform that improves health outcomes. Read more here.

Read the full article in Research!America